What's new? Log in Free sign up

Filing search / ALX Oncology Holdings Inc. / "Tax"

Search information

ALX Oncology Holdings Inc.

Companies

"Tax"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

81 results

Newest first Best match first

ALXO ALX Oncology Holdings Inc.

Shelf registration

; any applicable material U.S. federal income tax consequences; the identity of the warrant agent for the warrants and of any other depositaries … of certain U.S. federal income tax considerations applicable to the purchase contracts; whether the purchase contracts will be issued in fully

6 Mar 25

5:26pm

ALXO ALX Oncology Holdings Inc.

then in place under which the equity award is granted. Outside Directors will be solely responsible for any tax obligations they incur as a result … comply with the requirements of Section 409A so that none of the compensation provided hereunder will be subject to the additional tax imposed under

6 Mar 25

4:33pm

ALXO ALX Oncology Holdings Inc.

or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver … Medicare drugs, imposing penalties and excise tax for manufacturers that fail to comply with the drug price negotiation requirements, requiring inflation

6 Mar 25

4:33pm

ALXO ALX Oncology Holdings Inc.

thereunder (“Section 409A”), so that none of the payments and benefits to be provided hereunder will be subject to the additional tax imposed by Section

6 Mar 25

4:33pm

ALXO ALX Oncology Holdings Inc.

, restricted stock units, and restricted stock Exercise of stock options for cash and tax withholding requirements Purchases from the employee stock purchase … activity associated with such securities. Exercise of stock options for cash and tax withholding requirements The trading restrictions under

6 Mar 25

4:33pm

9dqogjuui aazwf5v

6 Mar 25

4:33pm

i41if3i4ed7y uj

Departure of Directors or Certain Officers

Registration of securities for employees

Issuer tender offer statement

Issuer tender offer statement

Issuer tender offer statement

Issuer tender offer statement

ig04kwnfk40s 9wa

Quarterly report

7 Nov 24

4:06pm

r9ikitkxn1vebrpg8u

Quarterly report

7 Nov 24

4:06pm

Quarterly report

12 Aug 24

4:03pm

f5adbljwdnklr4s

Quarterly report

9 May 24

4:10pm

Definitive proxy

22 Apr 24

4:01pm

o13jsf4 2515keugr

7 Mar 24

4:11pm

rl738pq0r33l6rkn um

7 Mar 24

4:11pm

irhusu 5xtau0psmrv

ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Prev
1
2
3
4
5
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.